Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Development and characterization of novel 2'-F-RNA aptamers specific to human total and glycated hemoglobins.

Davydova A, Vorobyeva M, Bashmakova E, Vorobjev P, Krasheninina O, Tupikin A, Kabilov M, Krasitskaya V, Frank L, Venyaminova A.

Anal Biochem. 2019 Feb 8. pii: S0003-2697(18)31232-6. doi: 10.1016/j.ab.2019.02.004. [Epub ahead of print]

PMID:
30742800
2.

Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells.

Krasheninina OA, Apartsin EK, Fuentes E, Szulc A, Ionov M, Venyaminova AG, Shcharbin D, de la Mata FJ, Bryszewska M, Gόmez R.

Pharmaceutics. 2019 Jan 10;11(1). pii: E25. doi: 10.3390/pharmaceutics11010025.

3.

Hydrogels of Polycationic Acetohydrazone-Modified Phosphorus Dendrimers for Biomedical Applications: Gelation Studies and Nucleic Acid Loading.

Apartsin EK, Grigoryeva AE, Malrin-Fournol A, Ryabchikova EI, Venyaminova AG, Mignani S, Caminade AM, Majoral JP.

Pharmaceutics. 2018 Aug 6;10(3). pii: E120. doi: 10.3390/pharmaceutics10030120.

4.

Key Aspects of Nucleic Acid Library Design for in Vitro Selection.

Vorobyeva MA, Davydova AS, Vorobjev PE, Venyaminova AG.

Int J Mol Sci. 2018 Feb 5;19(2). pii: E470. doi: 10.3390/ijms19020470. Review.

5.

Nuclease-resistant 63-bp trimeric siRNAs simultaneously silence three different genes in tumor cells.

Gvozdeva OV, Gladkih DV, Chernikov IV, Meschaninova MI, Venyaminova AG, Zenkova MA, Vlassov VV, Chernolovskaya EL.

FEBS Lett. 2018 Jan;592(1):122-129. doi: 10.1002/1873-3468.12927. Epub 2017 Dec 29.

6.

Recent Advances in Nucleic Acid Targeting Probes and Supramolecular Constructs Based on Pyrene-Modified Oligonucleotides.

Krasheninina OA, Novopashina DS, Apartsin EK, Venyaminova AG.

Molecules. 2017 Nov 30;22(12). pii: E2108. doi: 10.3390/molecules22122108. Review.

7.

Structural rearrangements in mRNA upon its binding to human 80S ribosomes revealed by EPR spectroscopy.

Malygin AA, Graifer DM, Meschaninova MI, Venyaminova AG, Timofeev IO, Kuzhelev AA, Krumkacheva OA, Fedin MV, Karpova GG, Bagryanskaya EG.

Nucleic Acids Res. 2018 Jan 25;46(2):897-904. doi: 10.1093/nar/gkx1136.

8.

Structural features of the interaction of the 3'-untranslated region of mRNA containing exosomal RNA-specific motifs with YB-1, a potential mediator of mRNA sorting.

Yanshina DD, Kossinova OA, Gopanenko AV, Krasheninina OA, Malygin AA, Venyaminova AG, Karpova GG.

Biochimie. 2018 Jan;144:134-143. doi: 10.1016/j.biochi.2017.11.007. Epub 2017 Nov 11.

PMID:
29133115
9.

Amphiphilic carbosilane dendrons as a novel synthetic platform toward micelle formation.

Gutierrez-Ulloa CE, Buyanova MY, Apartsin EK, Venyaminova AG, de la Mata FJ, Valiente M, Gómez R.

Org Biomol Chem. 2017 Sep 13;15(35):7352-7364. doi: 10.1039/c7ob01331k.

PMID:
28829094
10.

Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications.

Vorobyeva M, Vorobjev P, Venyaminova A.

Molecules. 2016 Nov 25;21(12). pii: E1613. Review.

11.

Aptamers Against Immunologic Targets: Diagnostic and Therapeutic Prospects.

Vorobyeva M, Timoshenko V, Vorobjev P, Venyaminova A.

Nucleic Acid Ther. 2016 Feb;26(1):52-65. doi: 10.1089/nat.2015.0568. Epub 2015 Dec 7. Review.

PMID:
26643948
12.

Method of carrier-free delivery of therapeutic RNA importable into human mitochondria: Lipophilic conjugates with cleavable bonds.

Dovydenko I, Tarassov I, Venyaminova A, Entelis N.

Biomaterials. 2016 Jan;76:408-17. doi: 10.1016/j.biomaterials.2015.10.075. Epub 2015 Oct 31.

13.

Aptamers against pathogenic microorganisms.

Davydova A, Vorobjeva M, Pyshnyi D, Altman S, Vlassov V, Venyaminova A.

Crit Rev Microbiol. 2016 Nov;42(6):847-65. doi: 10.3109/1040841X.2015.1070115. Epub 2015 Aug 10. Review.

14.

Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction.

Ionov M, Lazniewska J, Dzmitruk V, Halets I, Loznikova S, Novopashina D, Apartsin E, Krasheninina O, Venyaminova A, Milowska K, Nowacka O, Gomez-Ramirez R, de la Mata FJ, Majoral JP, Shcharbin D, Bryszewska M.

Int J Pharm. 2015 May 15;485(1-2):261-9. doi: 10.1016/j.ijpharm.2015.03.024. Epub 2015 Mar 16.

PMID:
25791760
15.

Mitochondrial targeting of recombinant RNA.

Dovydenko I, Heckel AM, Tonin Y, Gowher A, Venyaminova A, Tarassov I, Entelis N.

Methods Mol Biol. 2015;1265:209-25. doi: 10.1007/978-1-4939-2288-8_16.

PMID:
25634278
16.

2'-Bispyrene-modified 2'-O-methyl RNA probes as useful tools for the detection of RNA: synthesis, fluorescent properties, and duplex stability.

Krasheninina OA, Novopashina DS, Lomzov AA, Venyaminova AG.

Chembiochem. 2014 Sep 5;15(13):1939-46. doi: 10.1002/cbic.201402105. Epub 2014 Jul 18.

PMID:
25044697
17.

Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.

Tonin Y, Heckel AM, Vysokikh M, Dovydenko I, Meschaninova M, Rötig A, Munnich A, Venyaminova A, Tarassov I, Entelis N.

J Biol Chem. 2014 May 9;289(19):13323-34. doi: 10.1074/jbc.M113.528968. Epub 2014 Apr 1.

18.

42- and 63-bp anti-MDR1-siRNAs bearing 2'-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencing.

Gvozdeva OV, Dovydenko IS, Venyaminova AG, Zenkova MA, Vlassov VV, Chernolovskaya EL.

FEBS Lett. 2014 Mar 18;588(6):1037-43. doi: 10.1016/j.febslet.2014.02.015. Epub 2014 Feb 20.

19.

RNA aptamer against autoantibodies associated with multiple sclerosis and bioluminescent detection probe on its basis.

Vorobjeva MA, Krasitskaya VV, Fokina AA, Timoshenko VV, Nevinsky GA, Venyaminova AG, Frank LA.

Anal Chem. 2014 Mar 4;86(5):2590-4. doi: 10.1021/ac4037894. Epub 2014 Feb 20.

PMID:
24512542
20.

Multipyrene tandem probes for point mutations detection in DNA.

Kholodar SA, Novopashina DS, Meschaninova MI, Venyaminova AG.

J Nucleic Acids. 2013;2013:860457. doi: 10.1155/2013/860457. Epub 2013 Dec 24.

Supplemental Content

Loading ...
Support Center